Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2020

01-04-2020 | Human Immunodeficiency Virus | Original Paper

Understanding the Prevalence of Smoking Among People Living with HIV (PLHIV) in Australia and Factors Associated with Smoking and Quitting

Authors: Stephanie K. Edwards, Judith Dean, Jennifer Power, Peter Baker, Coral Gartner

Published in: AIDS and Behavior | Issue 4/2020

Login to get access

Abstract

Understanding contributors to smoking and quitting cigarettes is important to developing effective cessation programs and addressing smoking related morbidity and mortality among people living with HIV (PLHIV). Using data from a large cross-sectional study of Australian PLHIV we provide a smoking prevalence estimate and explore the relationship between socio-demographic variables and smoking status. We also explore the relationship between HIV diagnosis and antiretroviral therapy (ART) initiation and quitting smoking. Of the 1011 respondents included in the analysis, 30.6% were current smokers. The strongest predictor of smoking was regular cannabis use (AOR 6.2, 95% CI 3.6–10.8) while the strongest predictor of being a past smoker was receiving ART (AOR 2.4, 95% CI 1.2–4.7). Quitting also increased around the time of diagnosis and ART initiation, highlighting the potential for these events to be optimal times to address smoking among PLHIV.
Appendix
Available only for authorised users
Literature
1.
Benard A, Bonnet F, Tessier J-F, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 aquitaine cohort. AIDS Patient Care ST. 2007;21(7):458–68.CrossRef
2.
Gritz ER, Danysh HE, Fletcher FE, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV. Clin Infect Dis. 2013;57(4):608–15.CrossRefPubMedPubMedCentral
3.
Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.CrossRefPubMed
4.
Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health. 2006;96(6):1060–5.CrossRefPubMedPubMedCentral
5.
Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824–35.CrossRefPubMed
6.
Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV + men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30:371–83.CrossRefPubMedPubMedCentral
7.
Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health. 2010;100(10):1896–903.CrossRefPubMedPubMedCentral
8.
Marshall MM, Kirk GD, Caporaso NE, et al. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav. 2011;36:61–7.CrossRefPubMed
9.
Elf JL, Variava E, Chon S, et al. Prevalence and correlates of smoking among people living with HIV in South Africa. Nicotine Tob Res. 2018;20(9):1124–31.CrossRefPubMed
10.
Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44.CrossRefPubMed
11.
Regan S, Meigs JB, Grinspoon SK, Triant VA. Determinants of smoking and quitting in HIV-infected individuals. PLoS ONE. 2016;11(4):e153103.CrossRef
12.
13.
Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29(2):221–9.CrossRefPubMed
14.
Savin MJ, Frank-Pearce SG, Pulvers K, Vidrine DJ. The association between lifetime polytobacco use and intention to quit among HIV-positive cigarette smokers. Drug Alcohol Depend. 2018;191:152–8.CrossRefPubMedPubMedCentral
15.
Ellard J. Smoking cessation interventions: a literature review [Internet]. National Federation of AIDs Organisations Inc, 2010.
16.
Akhtar-Khaleel WZ, Cook RL, Shoptaw S, et al. Trends and predictors of cigarette smoking among HIV seropositive and seronegative men: the multicenter aids cohort study. AIDS Behav. 2016;20(3):622–32.CrossRefPubMedPubMedCentral
17.
Mdege ND, Shah S, Ayo-Yusuf OA, Hakim J, Siddiqi K. Tobacco use among people living with HIV: analysis of data from demographic and health surveys from 28 low-income and middle-income countries. Lancet Glob Health. 2017;5(6):e578–92.CrossRefPubMedPubMedCentral
18.
Garrett BE, Dube SR, Babb S, McAfee T. Addressing the social determinants of hto reduce tobacco-related disparities. Nicotine Tob Res. 2015;17(8):892–7.CrossRefPubMed
19.
Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev. 2009;21(3 Suppl):54–64.CrossRefPubMedPubMedCentral
20.
21.
22.
Pacek LR, Crum RM. A review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts. Addict Res Theory. 2015;23(1):10–23.CrossRefPubMed
23.
Colon-Lopez V, Gonzalez-Barrios D, De Leon SM, et al. Population-based study of tobacco use among people living with HIV in Puerto Rico. Subst Use Misuse. 2018;53(3):420–5.CrossRefPubMed
24.
Bénard A, Tessier JF, Rambeloarisoa J, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis. 2006;10(4):378–83.PubMed
25.
Gritz ER, Vidrine DJ, Lazev AB, Amick BC III, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71–7.CrossRefPubMed
26.
Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand. 2005;12:41–7.CrossRef
27.
Uthman OA, Ekstrom AM, Moradi TT. Influence of socioeconomic position and gender on current cigarette smoking among people living with HIV in sub-Saharan Africa: disentangling context from composition. BMC Public Health. 2016;16:998.CrossRefPubMedPubMedCentral
28.
King D, Grasso C, Dant L, et al. Treatment outcomes associated with quitting cigarettes among sexual minority men living with HIV: antiretroviral adherence, engagement in care, and sustained HIV RNA suppression. AIDS Behav. 2018;22(9):2868–76.CrossRefPubMed
29.
McBride CM, Lipkus IM, Emmons KM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–70.CrossRefPubMed
30.
Collins RL, Kanouse DE, Gifford AL, et al. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol. 2001;20(5):351–60.CrossRefPubMed
31.
Vidrine DJ, Frank SG, Savin MJ, et al. HIV care initiation: a teachable moment for smoking cessation? Nicotine Tob Res. 2017;20(9):1109–16.CrossRefPubMedCentral
32.
Grierson J, Pitts M, Koelmeyer R. HIV futures seven: the health and wellbeing of HIV positive people in Australia. Melbourne: Latrobe University; 2013.
33.
IBM Corp. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp; Released 2015.
34.
Australian Bureau of Statistics. Australian health survey: first results, 2011–12 Canberra: Commonwealth of Australia, 2012.
35.
Fuster M, Estrada V, Fernandez-Pinilla MC, et al. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med. 2009;10:614–9.CrossRefPubMed
36.
Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013;27(1):22–32.CrossRefPubMed
37.
Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223–34.CrossRefPubMed
38.
Shepherd L, Ryom L, Law M, et al. Cessation of cigarette smoking and the impact on cancer incidence in human immunodeficiency virus-infected persons: the data collection on adverse events of anti-HIV drugs study. Clin Infect Dis. 2019;68(4):650–7.CrossRefPubMed
39.
Australian Institute of Health and Welfare (AIHW). Alcohol, tobacco and other drugs in Australia. Commonwealth of Australia, 2018.
40.
Cui Q, Robinson L, Elston D, et al. Safety and tolerability of varenicline tartrate (Champix((R))/Chantix((R))) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS. 2012;26(1):12–9.CrossRefPubMedPubMedCentral
41.
Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545–54.CrossRefPubMed
42.
Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV + smokers: a randomized controlled trial. Addiction. 2009;104(11):1891–900.CrossRefPubMedPubMedCentral
43.
Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20(2):253–60.CrossRefPubMed
44.
Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.CrossRefPubMed
45.
Scollo MM, Winstanley MH. Tobacco in Australia: facts and issues. Melbourne: Cancer Counc Vic; 2015.
46.
Brath H, Grabovac I, Schalk H, Degen O, Dorner TE. Prevalence and correlates of smoking and readiness to quit smoking in people living with HIV in Austria and Germany. PLoS ONE. 2016;11(2):e0150553.CrossRefPubMedPubMedCentral
47.
Bekele T, Rueda S, Gardner S, et al. Trends and correlates of cigarette smoking and its impacts on health-related quality of life among people living with HIV: findings from the Ontario HIV treatment network cohort study, 2008-2014. AIDS Patient Care STDS. 2017;31(2):49–59.CrossRefPubMed
48.
Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open. 2014;4(12):e006414.CrossRefPubMedPubMedCentral
49.
Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23(6):582–90.CrossRefPubMedPubMedCentral
50.
Grabovac I, Meilinger M, Schalk H, Leichsenring B, Dorner TE. Prevalence and associations of illicit drug and polydrug use in people living with HIV in Vienna. Sci Rep. 2018;8(1):8046.CrossRefPubMedPubMedCentral
51.
Garin N, Zurita B, Velasco C, et al. Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study. BMJ Open. 2017;7(1):e014105.CrossRefPubMedPubMedCentral
52.
Duval X, Baron G, Garelik D, et al. Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther. 2008;13(3):389–97.PubMedPubMedCentral
53.
Vijayaraghavan M, Penko J, Vittinghoff E, Bangsberg DR, Miaskowski C, Kushel MB. Smoking behaviors in a community-based cohort of HIV-infected indigent adults. AIDS Behav. 2014;18(3):535–43.CrossRefPubMedPubMedCentral
54.
Chew D, Steinberg MB, Thomas P, Swaminathan S, Hodder SL. Evaluation of a smoking cessation program for HIV infected individuals in an urban HIV clinic: challenges and lessons learned. AIDS Res Treat. 2014;2014:237834.PubMedPubMedCentral
55.
56.
Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731–6.CrossRefPubMed
57.
Brown G, Mikołajczak G, Lyons A, et al. Development and validation of PozQoL: a scale to assess quality of life of PLHIV. BMC Public Health. 2018;18(1):527.CrossRefPubMedPubMedCentral
58.
Pool ERM, Dogar O, Lindsay RP, Weatherburn P, Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016(6).
59.
Rabin RA, George TP. A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am J Addict. 2015;24(2):105–16.CrossRefPubMed
Metadata
Title
Understanding the Prevalence of Smoking Among People Living with HIV (PLHIV) in Australia and Factors Associated with Smoking and Quitting
Authors
Stephanie K. Edwards
Judith Dean
Jennifer Power
Peter Baker
Coral Gartner
Publication date
01-04-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02535-3

Other articles of this Issue 4/2020

AIDS and Behavior 4/2020 Go to the issue

Original Paper

Syphilis and HIV Co-infection in Mississippi: Implications for Control and Prevention

Original Paper

Multilevel Barriers to Engagement in the HIV Care Continuum Among Residents of the State of Rhode Island Living with HIV

Original Paper

Linkage to Care Following an HIV Diagnosis in Three Public Sector Clinics in eThekwini (Durban), South Africa: Findings from a Prospective Cohort Study

Original Paper

Perceptions of Community and Clinic-Based Adherence Clubs for Patients Stable on Antiretroviral Treatment: A Mixed Methods Study

Original Paper

Risk Factors Associated with HIV, Sexually Transmitted Infections (STI), and HIV/STI Co-infection Among Youth Living in the Slums of Kampala, Uganda

Original Paper

Behavioral and Cardiovascular Effects of a Behavioral Weight Loss Program for People Living with HIV
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits